So, finally, the authors combined somatic RET analysis with Ki67 assessment and showed that patients with somatic RET mutation and Ki67 expression level in >50 cells/mm2 could identify patients with a high risk of MTC-related death (10). This evidence concerns the gene MKI67 and medullary thyroid gland carcinoma.